Impact and benefit-cost ratio of a program for the management of latent tuberculosis infection among refugees in a region of Canada.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
05
11
2021
accepted:
14
04
2022
entrez:
19
5
2022
pubmed:
20
5
2022
medline:
24
5
2022
Statut:
epublish
Résumé
The identification and treatment of latent tuberculosis infection (LTBI) among immigrants from high-incidence regions who move to low-incidence countries is generally considered an ineffective strategy because only ≈14% of them comply with the multiple steps of the 'cascade of care' and complete treatment. In the Estrie region of Canada, a refugee clinic was opened in 2009. One of its goals is LTBI management. Key components of this intervention included: close collaboration with community organizations, integration within a comprehensive package of medical care for the whole family, timely delivery following arrival, shorter treatment through preferential use of rifampin, and risk-based selection of patients to be treated. Between 2009-2020, 5131 refugees were evaluated. To determine the efficacy and benefit-cost ratio of this intervention, records of refugees seen in 2010-14 (n = 1906) and 2018-19 (n = 1638) were reviewed. Cases of tuberculosis (TB) among our foreign-born population occurring before (1997-2008) and after (2009-2020) setting up the clinic were identified. All costs associated with TB or LTBI were measured. Out of 441 patients offered LTBI treatment, 374 (85%) were compliant. Adding other losses, overall compliance was 69%. To prevent one case of TB, 95.1 individuals had to be screened and 11.9 treated, at a cost of $16,056. After discounting, each case of TB averted represented $32,631, for a benefit-cost ratio of 2.03. Among nationals of the 20 countries where refugees came from, incidence of TB decreased from 68.2 (1997-2008) to 26.3 per 100,000 person-years (2009-2020). Incidence among foreign-born persons from all other countries not targeted by the intervention did not change. Among refugees settling in our region, 69% completed the LTBI cascade of care, leading to a 61% reduction in TB incidence. This intervention was cost-beneficial. Current defeatism towards LTBI management among immigrants and refugees is misguided. Compliance can be enhanced through simple measures.
Identifiants
pubmed: 35587499
doi: 10.1371/journal.pone.0267781
pii: PONE-D-21-35333
pmc: PMC9119458
doi:
Banques de données
Dryad
['10.5061/dryad.n8pk0p2wm']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0267781Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Lancet Infect Dis. 2016 Nov;16(11):1269-1278
pubmed: 27522233
Front Public Health. 2019 Mar 21;7:57
pubmed: 30949466
Int J Tuberc Lung Dis. 2008 May;12(5):498-505
pubmed: 18419884
N Engl J Med. 2018 Aug 2;379(5):454-463
pubmed: 30067928
Can Respir J. 2016;2016:7980869
pubmed: 27445565
BMJ. 2020 Mar 10;368:m549
pubmed: 32156698
Ann Intern Med. 2020 Aug 4;173(3):169-178
pubmed: 32539440
Am J Epidemiol. 2022 Jan 24;191(2):255-270
pubmed: 34017976
BMC Infect Dis. 2016 May 17;16:204
pubmed: 27184748
BMC Infect Dis. 2016 Nov 15;16(1):679
pubmed: 27846812
N Engl J Med. 2018 Aug 2;379(5):440-453
pubmed: 30067931
Clin Infect Dis. 2021 Nov 2;73(9):e3486-e3495
pubmed: 32556316
CMAJ. 2011 Sep 6;183(12):E939-51
pubmed: 20634392
Value Health. 2008 Sep-Oct;11(5):842-52
pubmed: 18489519
Can Commun Dis Rep. 2019 Feb 07;45(2-3):67-74
pubmed: 31015821
CMAJ. 2018 Feb 26;190(8):E209-E216
pubmed: 29483329
Clin Infect Dis. 2019 Nov 27;69(12):2101-2108
pubmed: 30856258
CMAJ. 2015 Nov 3;187(16):E473-E481
pubmed: 26416993
Nat Med. 2020 Dec;26(12):1941-1949
pubmed: 33077958
Eur Respir J. 2011 Oct;38(4):895-902
pubmed: 21436350
Int J Tuberc Lung Dis. 2007 Jan;11(1):16-26
pubmed: 17217125
Can J Public Health. 2008 Sep-Oct;99(5):391-6
pubmed: 19009923